Dopamine D2 receptor-dependent modulation of striatal NO synthase activity

Psychopharmacology

Volumn 191, Issue 3, 2007, Pages 793-803

  Sammut, Stephen ^a   Bray, Kristina E ^a   West, Anthony R ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Antipsychotic drugs; Basal ganglia; Nitric oxide; Schizophrenia

Indexed keywords

6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DOPAMINE 2 RECEPTOR; ETICLOPRIDE; METHYLENE BLUE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; QUINPIROLE; BENZAZEPINE DERIVATIVE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; ENZYME INHIBITOR; NEUROLEPTIC AGENT; NOS1 PROTEIN, RAT; SALICYLAMIDE DERIVATIVE; SK&F 81297; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC TRANSMISSION; ELECTROSTIMULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SYNTHESIS; EVOKED RESPONSE; MALE; MEMBRANE DEPOLARIZATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SUBSTANTIA NIGRA; SYNAPTIC TRANSMISSION; UPREGULATION; ANIMAL; BASAL GANGLION; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; METABOLISM; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; ANTIPSYCHOTIC AGENTS; BASAL GANGLIA; BENZAZEPINES; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; ELECTRIC STIMULATION; ENZYME INHIBITORS; MALE; METHYLENE BLUE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SALICYLAMIDES; SUBSTANTIA NIGRA; TIME FACTORS;

EID: 33847607976     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-006-0681-z     Document Type: Article

References (64)

1. Akbarian S, Bunney WE Jr, Potkin SG, Wigal SB, Hagman JO, Sandman CA, Jones EG (1993a) Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch Gen Psychiatry 50:169-177
2. Akbarian S, Vinuela A, Kim JJ, Potkin SG, Bunney WE Jr, Jones EG (1993b) Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Arch Gen Psychiatry 50:178-187
3. Altar CA, Boyar WC, Kim HS (1990) Discriminatory roles for D1 and D2 dopamine receptor subtypes in the in vivo control of neostriatal cyclic GMP. Eur J Pharmacol 181:17-21
4. Ariano MA (1983) Distribution of components of the guanosine 3′,5′-phosphate system in rat caudate-putamen. Neuroscience 10:707-723
5. Bamford NS, Zhang H, Schmitz Y, Wu NP, Cepeda C, Levine MS, Schmauss C, Zakharenko SS, Zablow L, Sulzer D (2004) Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals. Neuron 42:653-663
6. Berretta S, Parthasarathy HB, Graybiel AM (1997) Local release of GABAergic inhibition in the motor cortex induces immediateearly gene expression in indirect pathway neurons of the striatum. J Neurosci 17:4752-4763
7. Bester AM, Harvey BH (2000) Early suppression of striatal cyclic GMP may predetermine the induction and severity of chronic haloperidol-induced vacous chewing movements. Metab Brain Dis 15:275-285
8. Bevan MD, Booth PA, Eaton SA, Bolam JP (1998) Selective innervation of neostriatal interneurons by a subclass of neuron in the globus pallidus of the rat. J Neurosci 18:9438-9452
9. Black MD, Selk DE, Hitchcock JM, Wettstein JG, Sorensen SM (1999) On the effect of neonatal nitric oxide synthase inhibition in rats: a potential neurodevelopmental model of schizophrenia. Neuropharmacology 38:1299-1306
10. Black MD, Simmonds J, Senyah Y,Wettstein JG (2002) Neonatal nitric oxide synthase inhibition: social interaction deficits in adulthood and reversal by antipsychotic drugs. Neuropharmacology 42:414-420
11. Boehning D, Snyder SH (2003) Novel neural modulators. Annu Rev Neurosci 26:105-131
12. Calabresi P, Centonze D, Gubellini P, Marfia GA, Pisani A, Sancesario G, Bernardi G (2000) Synaptic transmission in the striatum: from plasticity to neurodegeneration. Prog Neurobiol 61:231-265
13. Calabresi P, Centonze D, Gubellini P, Marfia GA, Bernardi G (1999a) Glutamate-triggered events inducing corticostriatal long-term depression. J Neurosci 19:6102-6110
14. Calabresi P, Gubellini P, Centonze D, Sancesario G, Morello M, Giorgi M, Pisani A, Bernardi G (1999b) A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression. J Neurosci 19:2489-2499
15. Cavas M, Navarro JF (2002) Coadministration of -NOARG and tiapride: Effects on catalepsy in male mice. Prog Neuropsychopharmacol Biol Psychiatry 26:69-73
16. 1-like receptors excites LTS interneurons of the striatum. Eur J Neurosci 1 5:2049-2052
17. Centonze D, Grande C, Saulle E, Martin AB, Gubellini P, Pavon N, Pisani A, Bernardi G, Moratalla R, Calabresi P (2003) Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity. J Neurosci 23:8506-8512
18. Del Bel EA, Guimaraes FS, Bermúdez-Echeverry M, Gomes MZ, Schiaveto-de-souza A, Padovan-Neto FE, Tumas V, Barion-Cavalcanti AP, Lazzarini M, Nucci-da-Silva LP, de Paula-Souza D (2005) Role of nitric oxide on motor behavior. Cell Mol Neurobiol 25:371-392
19. Delgado A, Sierra A, Querejeta E, Valdiosera RF, Aceves J (2000) Inhibitory control of the GABAergic transmission in the rat neostriatum by D2 dopamine receptors. Neuroscience 95:1043-1048
20. Deutsch SI, Rosse RB, Paul SM, Tomasino V, Koetzner L, Morn CB, Mastropaolo J (1996) 7-Nitroindazole and methylene blue, inhibitors of neuronal nitric oxide synthase and NO-stimulated guanylate cyclase, block MK-801-elicited behaviors in mice. Neuropsychopharmacology 15:37-43
21. Di Stefano A, Sozio P, Cacciatore I, Cocco A, Giorgioni G, Costa B, Montali M, Lucacchini A, Martini C, Spoto G, Di Pietrantonio F, Di Matteo E, Pinnen F (2005) Preparation and pharmacological characterization of trans-2-amino-5(6)-fluoro-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as D2-like dopamine receptor agonists. J Med Chem 48:2646-2654
22. French SJ, Ritson GP, Hidaka S, Totterdell S (2005) Nucleus accumbens nitric oxide immunoreactive interneurons receive nitric oxide and ventral subicular afferents in rats. Neuroscience 135:121-131
23. Fujiyama F, Masuko S (1996) Association of dopaminergic terminals and neurons releasing nitric oxide in the rat striatum: an electron microscopic study using NADPH-diaphorase histochemistry and tyrosine hydroxylase immunohistochemistry. Brain Res Bull 40:121-127
24. Gattaz WF, Cramer H, Beckmann H (1984) Haloperidol increases the cerebrospinal fluid concentrations of cyclic GMP in schizophrenic patients. Biol Psychiatry 19:1229-1235
25. Griffith OW, Stuehr DJ (1995) Nitric oxide synthases: properties and catalytic mechanism. Annu Rev Physiol 57:707-734
26. Harvey BH, Bester A (2000) Withdrawal-associated changes in peripheral nitrogen oxides and striatal cyclic GMP after chronic haloperidol treatment. Behav Brain Res 111:203-211
27. Hidaka S, Totterdell S (2001) Ultrastructural features of the nitric oxide synthase-containing interneurons in the nucleus accumbens and their relationship with tyrosine hydroxylase-containing terminals. J Comp Neurol 431:139-154
28. Hyland BI, Reynolds JNJ, Hay J, Perk CG, Miller R (2002) Firing modes of midbrain dopamine cells in the freely moving rat. Neuroscience 114:475-492
29. Kaster MP, Rosa AO, Santos AR, Rodrigues AL (2005) Involvement of nitric oxide-cGMP pathway in the antidepressant-like effects of adenosine in the forced swimming test. Int J Neuropsychopharmacol 8:601-606
30. Kawaguchi Y (1993) Physiological, morphological, and histochemical characterization of three classes of interneurons in rat neostriatum. J Neurosci 13:4908-4923
31. Kawaguchi Y (1997) Neostriatal cell subtypes and their functional roles. Neurosci Res 27:1-8
32. Kubota Y, Mikawa S, Kawaguchi Y (1993) Neostriatal GABAergic interneurones contain NOS, calretinin or parvalbumin. Neuroreport 5:205-208
33. Lau YS, Petroske E, Meredith GE, Wang JQ (2003) Elevated neuronal nitric oxide synthase expression in chronic haloperidol-treated rats. Neuropharmacology 45:986-994
34. Lauer M, Johannes S, Fritzen S, Senitz D, Riederer P, Reif A (2005) Morphological abnormalities in nitric-oxide-synthase-positive striatal interneurons of schizophrenic patients. Neuropsychobiology 52:111-117
35. Lavin A, Nogueira L, Lapish CC, Wightman RM, Phillips PEM, Seamans JK (2005) Mesocortical dopamine neurons operate in distinct temporal domains using multimodal signaling. J Neurosci 25:5013-5023
36. Liou YJ, Tsai SJ, Hong CJ, Liao DL (2003) Association analysis for the CA repeat polymorphism of the neuronal nitric oxide synthase (NOS1) gene and schizophrenia. Schizophr Res 65:57-59
37. Luo D, Das S, Vincent SR (1995) Effects of methylene blue and LY83583 on neuronal nitric oxide synthase and NADPH-diaphorase. Eur J Pharmacol 290:247-251
38. Mayer B, Brunner F, Schmidt K (1993) Inhibition of nitric oxide synthesis by methylene blue. Biochem Pharmacol 45:367-374
39. Morello M, Reiner A, Sancesario G, Karle EJ, Bernardi G (1997) Ultrastructural study of nitric oxide synthase-containing striatal neurons and their relationship with parvalbumin-containing neurons in rats. Brain Res 776:30-39
40. Morris BJ, Simpson CS,Mundell S,Maceachern K, JohnstonHM, Nolan AM (1997) Dynamic changes in NADPH-diaphorase staining reflect activity of nitric oxide synthase: evidence for a dopaminergic regulation of striatal nitric oxide release. Neuropharmacology 36:1589-1599
41. Ohta K, Rosner G, Graf R (1997) Nitric oxide generation from sodium nitroprusside and hydroxylamine in brain. Neuroreport 8:2229-2235
42. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 4th edn. Academic, New York
43. Reif A, Herterich S, Strobel A, Ehlis AC, Saur D, Jacob CP, Wienker T, Topner T, Fritzen S, Walter U, Schmitt A, Fallgatter AJ, Lesch KP (2006) A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function. Mol Psychiatry 11:286-300
44. Rivera A, Alberti I, Martin AB, Narvaez JA, de la Calle A, Moratalla R (2002) Molecular phenotype of rat striatal neurons expressing the dopamine D5 receptor subtype. Eur J Neurosci 16:2049-2058
45. Salin P, Kerkerian-Le GL, Heidet V, Epelbaum J, Nieoullon A (1990) Somatostatin-immunoreactive neurons in the rat striatum: effects of corticostriatal and nigrostriatal dopaminergic lesions. Brain Res 521:23-32
46. Sammut S, Dec A, Mitchell D, Linardakis J, Ortiguela M, West AR (2006) Phasic dopaminergic transmission increases NO efflux in the rat dorsal striatum via a neuronal NOS and a dopamine D(1/ 5) receptor-dependent mechanism. Neuropsychopharmacology 31:493-505
47. Sancesario G, Morello M, Reiner A, Giacomini P, Massa R, Schoen S, Bernardi G (2000) Nitrergic neurons make synapses on dualinput dendritic spines of neurons in the cerebral cortex and the striatum of the rat: implication for a postsynaptic action of nitric oxide. Neuroscience 99:627-642
48. Shinkai T, Ohmori O, Hori H, Nakamura J (2002) Allelic association of the neuronal nitric oxide synthase (NOS1) gene with schizophrenia. Mol Psychiatry 7:560-563
49. Siuciak JA, Chapin DS, Harms JF, Lebel LA, McCarthy SA, Chambers L, Shrikhande A, Wong S, Menniti FS, Schmidt CJ (2006a) Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis. Neuropharmacology 51:386-396
50. Siuciak JA, McCarthy SA, Chapin DS, Fujiwara RA, James LC, Williams RD, Stock JL, McNeish JD, Strick CA, Menniti FS, Schmidt CJ (2006b) Genetic deletion of the striatum-enriched phosphodiesterase PDE10A: evidence for altered striatal function. Neuropharmacology 51:374-385
51. Starr MS, Starr BS (1995) Do NMDA receptor-mediated changes in motor behaviour involve nitric oxide? Eur J Pharmacol 272:211-217
52. Tseng KY, O'Donnell P (2004) Dopamine-glutamate interactions controlling prefrontal cortical pyramidal cell excitability involve multiple signaling mechanisms. J Neurosci 24:5131-5139
53. Vincent SR (1994) Nitric oxide: a radical neurotransmitter in the central nervous system. Prog Neurobiol 42:129-160
54. Volke V, Wegener G, Vasar E, Rosenberg R (1999) Methylene blue inhibits hippocampal nitric oxide synthase activity in vivo. Brain Res 826:303-305
55. Vuillet J, Kerkerian L, Kachidian P, Bosler O, Nieoullon A (1989) Ultrastructural correlates of functional relationships between nigral dopaminergic or cortical afferent fibers and neuropeptide Y-containing neurons in the rat striatum. Neurosci Lett 100:99-104
56. Vuillet J, Dimova R, Nieoullon A, Goff LK-L (1992) Ultrastructural relationships between choline acetyltransferase- and neuropeptide Y-containing neurons in the rat striatum. Neuroscience 46:351-360
57. Wang H, Pickel VM (2002) Dopamine D2 receptors are present in prefrontal cortical afferents and their targets in patches of the rat caudate-putamen nucleus. J Comp Neurol 442:392-404
58. Wang Z, Kai L, Day M, Ronesi J, Yin HH, Ding J, Tkatch T, Lovinger DM, Surmeier DJ (2006) Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. Neuron 50:443-452
59. West AR, Galloway MP (1997) Endogenous nitric oxide facilitates striatal dopamine and glutamate efflux in vivo: role of ionotropic glutamate receptor-dependent mechanisms. Neuropharmacology 36:1571-1581
60. West AR, Grace AA (2004) The nitric oxide-guanylyl cyclase signaling pathway modulates membrane activity states and electrophysiological properties of striatal medium spiny neurons recorded in vivo. J Neurosci 24:1924-1935
61. West AR, Galloway MP, Grace AA (2002) Regulation of striatal dopamine neurotransmission by nitric oxide: effector pathways and signaling mechanisms. Synapse 44:227-245
62. Wolin MS, Cherry PD, Rodenburg JM, Messina EJ, Kaley G (1990) Methylene blue inhibits vasodilation of skeletal muscle arterioles to acetylcholine and nitric oxide via the extracellular generation of superoxide anion. J Pharmacol Exp Ther 254:872-876
63. Xing G, Chavko M, Zhang LX, Yang S, Post RM (2002) Decreased calcium-dependent constitutive nitric oxide synthase (cNOS) activity in prefrontal cortex in schizophrenia and depression. Schizophr Res 58:21-30
64. Zhang X (2004) Real time and in vivo monitoring of nitric oxide by electrochemical sensors - from dream to reality. Front Biosci 9:3434-3446